LY900003

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Carcinoma, Non-Small-Cell LungNeoplasms, LungPulmonary Neoplasms

Phase 2

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

CompletedNCT00042679

Eli Lilly and CompanyCarcinoma, Non-Small-Cell Lung, Neoplasms, Lung, Pulmonary Neoplasms

Start: 2002-06-30Updated: 2006-07-19

Phase 3

A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer

CompletedNCT00034268

Eli Lilly and CompanyCarcinoma, Non-Small-Cell Lung

Start: 2002-03-31Updated: 2006-07-19